相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Maria A. de Winter et al.
THROMBOSIS AND HAEMOSTASIS (2022)
In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
Geraldine Poenou et al.
CANCERS (2022)
Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
Nicola Ferri et al.
PHARMACEUTICS (2022)
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study
Walter Ageno et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal
Maria A. de Winter et al.
THROMBOSIS RESEARCH (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score
Romain Chopard et al.
CHEST (2021)
Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
Alvaro Alonso et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients
Carlos Martinez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
D-dimer levels enhance the discriminatory capacity of bleeding risk scores for predicting in-hospital bleeding events in acute pulmonary embolism
Marta Skowronska et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation
E. Seiler et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists
Marcello Di Nisio et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Frederikus A. Klok et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists
Marcello Di Nisio et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
G. S. Collins et al.
BRITISH JOURNAL OF CANCER (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
Jose Antonio Nieto et al.
THROMBOSIS RESEARCH (2013)
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism.: Findings from the RIETE Registry
Nuria Ruiz-Gimenez et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Management of thrombosis in cancer: primary prevention and secondary prophylaxis
AYY Lee
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)